90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple...
90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma
About this item
Full title
Author / Creator
Tuazon, Sherilyn A. , Sandmaier, Brenda M. , Gooley, Theodore A. , Fisher, Darrell R. , Holmberg, Leona A. , Becker, Pamela S. , Lundberg, Sally J. , Orozco, Johnnie J. , Gopal, Ajay K. , Till, Brian G. , Coffey, David G. , Nartea, Margaret E. , Matesan, Manuela C. , Pagel, John M. , Rajendran, Joseph G. , Press, Oliver W. , Bensinger, William I. and Green, Damian J.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
To improve disease control without increasing the toxicity of a reduced-intensity allogeneic hematopoietic cell transplantation (HCT) in multiple myeloma (MM), a phase I trial was performed using an antibody-radionuclide conjugate targeting CD45 (
90
Y-DOTA-BC8) as conditioning.
90
Y-DOTA-BC8 was combined with fludarabine and low-dose T...
Alternative Titles
Full title
90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma
Authors, Artists and Contributors
Author / Creator
Sandmaier, Brenda M.
Gooley, Theodore A.
Fisher, Darrell R.
Holmberg, Leona A.
Becker, Pamela S.
Lundberg, Sally J.
Orozco, Johnnie J.
Gopal, Ajay K.
Till, Brian G.
Coffey, David G.
Nartea, Margaret E.
Matesan, Manuela C.
Pagel, John M.
Rajendran, Joseph G.
Press, Oliver W.
Bensinger, William I.
Green, Damian J.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8328580
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8328580
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/s41409-020-01000-3
